Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
PGIM Jennison Health Sciences Fund · Prudential Sector Funds, Inc.
55 holdings · as of 2026-05-29 (3.6 months ago) The fund may have traded since. SEC Form N-PORT is filed quarterly and lags the period it covers, so these are the most recent holdings on file, not the fund’s holdings today.
This fund holds short positions, so exposure is counted gross — long and short both count as exposure rather than netting off, and the weights below therefore sum to 102% of net assets rather than 100%. Shares of the portfolio are shown as shares of that gross exposure.
NON-COMPLIANT At least 15.00% of portfolio weight is in non-compliant holdings — already over the 5% threshold, so the verdict is settled whatever the unmatched 32% turns out to be. Matching more holdings can only raise this share, never lower it.
55 holdings, 25 matched (68% of weight). Portfolio as of 2026-05-29, filed 2026-07-27. Source: SEC Form N-PORT.
3.74% of this portfolio’s income is non-permissible — weighted across holdings, computed over 60% of portfolio weight (19 of 55 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
Portfolio shares are withheld: coverage is below the floor needed to state one. The holdings themselves are below, because the names are evidence you can check.
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| LLY ELI LILLY & COMPANY | COMPLIANT | 17.35% | AAOIFI5.2% Usmani38.6% Dow Jones Islamic6.4% S&P Shariah6.9% MSCI Islamic38.6% MSCI Islamic M-Series6.9% FTSE Shariah38.6% |
| MRK MERCK & COMPANY INC | COMPLIANT | 6.06% | AAOIFI14.7% Usmani41.5% Dow Jones Islamic21.8% S&P Shariah20.9% MSCI Islamic41.5% MSCI Islamic M-Series20.9% FTSE Shariah41.5% |
| UNH UNITEDHEALTH GROUP INC | NON_COMPLIANT | 5.87% | AAOIFI20.4% Usmani23.7% Dow Jones Islamic20.4% S&P Shariah18.8% MSCI Islamic23.7% MSCI Islamic M-Series18.8% FTSE Shariah23.7% |
| TMO THERMO FISHER SCIENTIFIC INC | COMPLIANT | 4.56% | AAOIFI20.5% Usmani40.3% Dow Jones Islamic23.4% S&P Shariah22.9% MSCI Islamic40.3% MSCI Islamic M-Series22.9% FTSE Shariah40.3% |
| ARGX ARGENX SE | COMPLIANT | 3.55% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| VRTX VERTEX PHARMACEUTICALS INC | COMPLIANT | 3.37% | AAOIFI1.6% Usmani7.2% Dow Jones Islamic1.7% S&P Shariah1.7% MSCI Islamic7.2% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| DHR DANAHER CORP | COMPLIANT | 3.28% | AAOIFI18.2% Usmani28.8% Dow Jones Islamic17.7% S&P Shariah16.7% MSCI Islamic28.8% MSCI Islamic M-Series16.7% FTSE Shariah28.8% |
| ISRG INTUITIVE SURGICAL INC | COMPLIANT | 3.07% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| LONN.SW LONZA GROUP AG | COMPLIANT | 3.02% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| CVS CVS HEALTH CORP | NON_COMPLIANT | 2.52% | AAOIFI61.7% Usmani30.1% Dow Jones Islamic84.9% S&P Shariah88.7% MSCI Islamic30.1% MSCI Islamic M-Series88.7% FTSE Shariah24.2% |
| (PIPA070) PGIM Core Government Money Market Fund | UNSCREENED | 2.50% | no in-house ratios for this holding |
| INSMED INC | UNSCREENED | 2.28% | no in-house ratios for this holding |
| ROIVANT SCIENCES LTD | UNSCREENED | 2.21% | no in-house ratios for this holding |
| SYK STRYKER CORP | COMPLIANT | 2.16% | AAOIFI14.6% Usmani32.2% Dow Jones Islamic11.3% S&P Shariah11.8% MSCI Islamic32.2% MSCI Islamic M-Series11.8% FTSE Shariah31.2% |
| SIONNA THERAPEUTICS INC | UNSCREENED | 2.01% | no in-house ratios for this holding |
| ONC BEONE MEDICINES LTD | COMPLIANT | 1.82% | AAOIFI2.8% Usmani12.5% Dow Jones Islamic0.3% S&P Shariah0.3% MSCI Islamic12.5% MSCI Islamic M-Series0.3% FTSE Shariah11.7% |
| VAXCYTE INC | UNSCREENED | 1.77% | no in-house ratios for this holding |
| ALGN ALIGN TECHNOLOGY INC | COMPLIANT | 1.75% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| A AGILENT TECHNOLOGIES INC | COMPLIANT | 1.73% | AAOIFI9.3% Usmani28.3% Dow Jones Islamic10.8% S&P Shariah10.7% MSCI Islamic28.3% MSCI Islamic M-Series10.7% FTSE Shariah28.3% |
| PALVELLA THERAPEUTICS INC | UNSCREENED | 1.56% | no in-house ratios for this holding |
| APOGEE THERAPEUTICS INC | UNSCREENED | 1.42% | no in-house ratios for this holding |
| CABA CABALETTA BIO INC | NON_COMPLIANT | 1.35% | AAOIFI1.0% Usmani10.0% Dow Jones Islamic2.4% S&P Shariah1.5% MSCI Islamic2.2% MSCI Islamic M-Series1.5% FTSE Shariah0.0% |
| PRUDENTIAL INVESTMENT PORTFOLIOS 9 | UNSCREENED | 1.31% | no in-house ratios for this holding |
| NEWAMSTERDAM PHARMA COMPANY NV | UNSCREENED | 1.30% | no in-house ratios for this holding |
| DIANTHUS THERAPEUTICS INC | UNSCREENED | 1.28% | no in-house ratios for this holding |
| KYMR KYMERA THERAPEUTICS INC | NON_COMPLIANT | 1.26% | AAOIFI0.8% Usmani4.8% Dow Jones Islamic1.7% S&P Shariah2.1% MSCI Islamic4.6% MSCI Islamic M-Series2.1% FTSE Shariah0.0% |
| SCHOLAR ROCK HOLDING CORP | UNSCREENED | 1.25% | no in-house ratios for this holding |
| CELCUITY INC | UNSCREENED | 1.07% | no in-house ratios for this holding |
| REVOLUTION MEDICINES INC | UNSCREENED | 1.06% | no in-house ratios for this holding |
| AZN ASTRAZENECA PLC | COMPLIANT | 1.06% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| MINERALYS THERAPEUTICS INC | UNSCREENED | 1.04% | no in-house ratios for this holding |
| TEVA PHARMACEUTICAL INDUSTRIES LTD | UNSCREENED | 1.00% | no in-house ratios for this holding |
| XENON PHARMACEUTICALS INC | UNSCREENED | 1.00% | no in-house ratios for this holding |
| DISC MEDICINE INC | UNSCREENED | 0.99% | no in-house ratios for this holding |
| PTGX PROTAGONIST THERAPEUTICS INC | NON_COMPLIANT | 0.97% | AAOIFI0.1% Usmani1.0% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic1.0% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| BAYN.DE BAYER AG | NON_COMPLIANT | 0.94% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| VERADERMICS INC | UNSCREENED | 0.93% | no in-house ratios for this holding |
| TNDM TANDEM DIABETES CARE INC | NON_COMPLIANT | 0.84% | AAOIFI53.4% Usmani64.0% Dow Jones Islamic49.0% S&P Shariah43.9% MSCI Islamic64.0% MSCI Islamic M-Series43.9% FTSE Shariah52.2% |
| ERASCA INC | UNSCREENED | 0.81% | no in-house ratios for this holding |
| CRINETICS PHARMACEUTICALS INC | UNSCREENED | 0.71% | no in-house ratios for this holding |
| TARS TARSUS PHARMACEUTICALS INC | COMPLIANT | 0.70% | AAOIFI2.3% Usmani14.5% Dow Jones Islamic3.8% S&P Shariah4.7% MSCI Islamic14.5% MSCI Islamic M-Series4.7% FTSE Shariah11.9% |
| IMMUNOVANT INC | UNSCREENED | 0.67% | no in-house ratios for this holding |
| AVALYN PHARMA INC | UNSCREENED | 0.66% | no in-house ratios for this holding |
| OLMA OLEMA PHARMACEUTICALS INC | NON_COMPLIANT | 0.63% | AAOIFI0.1% Usmani0.1% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.1% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| ELAN ELANCO ANIMAL HEALTH INC | NON_COMPLIANT | 0.62% | AAOIFI31.2% Usmani27.5% Dow Jones Islamic41.7% S&P Shariah45.2% MSCI Islamic27.5% MSCI Islamic M-Series45.2% FTSE Shariah27.5% |
| ARQT ARCUTIS BIOTHERAPEUTICS INC | COMPLIANT | 0.60% | AAOIFI3.8% Usmani23.4% Dow Jones Islamic5.0% S&P Shariah6.5% MSCI Islamic23.4% MSCI Islamic M-Series6.5% FTSE Shariah22.3% |
| SEAPORT THERAPEUTICS INC | UNSCREENED | 0.57% | no in-house ratios for this holding |
| ABIVAX SA | UNSCREENED | 0.54% | no in-house ratios for this holding |
| UNIQURE NV | UNSCREENED | 0.51% | no in-house ratios for this holding |
| LB PHARMACEUTICALS INC | UNSCREENED | 0.47% | no in-house ratios for this holding |
| TYRA TYRA BIOSCIENCES INC | COMPLIANT | 0.44% | AAOIFI0.3% Usmani1.5% Dow Jones Islamic0.5% S&P Shariah0.6% MSCI Islamic1.5% MSCI Islamic M-Series0.6% FTSE Shariah0.0% |
| ENLIVEN THERAPEUTICS INC | UNSCREENED | 0.36% | no in-house ratios for this holding |
| SPYRE THERAPEUTICS INC | UNSCREENED | 0.34% | no in-house ratios for this holding |
| ORUKA THERAPEUTICS INC | UNSCREENED | 0.32% | no in-house ratios for this holding |
| CABALETTA BIO INC WARRANT | UNSCREENED | 0.20% | no in-house ratios for this holding |
The published standards disagree about this fund by 27 points of portfolio weight — 49.6% of it passes AAOIFI, 22.3% passes Usmani. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 49.6% ratios fail on 9.1% 42.9% not rated under AAOIFI
ratios pass on 22.3% ratios fail on 36.5% 42.9% not rated under Usmani
ratios pass on 49.6% ratios fail on 9.1% 42.9% not rated under Dow Jones Islamic
ratios pass on 49.6% ratios fail on 9.1% 42.9% not rated under S&P Shariah
ratios pass on 22.3% ratios fail on 40.4% 38.9% not rated under MSCI Islamic
ratios pass on 49.6% ratios fail on 9.1% 42.9% not rated under MSCI Islamic M-Series
ratios pass on 22.3% ratios fail on 36.5% 42.9% not rated under FTSE Shariah
25 of 55 listed holdings carry our own per-methodology verdicts (70% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 20 (59% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| UNH UNITEDHEALTH GROUP INC | 5.87% |
| CVS CVS HEALTH CORP | 2.52% |
| CABA CABALETTA BIO INC | 1.35% |
| KYMR KYMERA THERAPEUTICS INC | 1.26% |
| PTGX PROTAGONIST THERAPEUTICS INC | 0.97% |
| BAYN.DE BAYER AG | 0.94% |
| TNDM TANDEM DIABETES CARE INC | 0.84% |
| OLMA OLEMA PHARMACEUTICALS INC | 0.63% |
| ELAN ELANCO ANIMAL HEALTH INC | 0.62% |
Methodology breakdown computing — it will appear here on its own.
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
PJHRX (PJHRX) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
Computing the full ratio and business-activity breakdown for PJHRX — this runs off the critical path so the page paints first. It will appear here on its own.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
This fund prices once a day, so its bars carry no intraday high or low — floor-trader pivots are not defined for it.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 40.50 | NEUTRAL |
| Stochastic %K (14) | 1.25 | BUY |
| CCI (20) | -114.51 | BUY |
| Williams %R (14) | -98.75 | BUY |
| MACD (12,26,9) | -0.20 | SELL |
| ROC (10) | -2.38 | SELL |
| Momentum (10) | -0.85 | SELL |
| EMA (10) | 35.33 | SELL |
| SMA (10) | 35.45 | SELL |
| EMA (20) | 35.56 | SELL |
| SMA (20) | 35.96 | SELL |
| EMA (30) | 35.53 | SELL |
| SMA (30) | 35.89 | SELL |
| EMA (50) | 35.19 | SELL |
| SMA (50) | 35.48 | SELL |
| EMA (100) | 34.18 | BUY |
| SMA (100) | 33.71 | BUY |
| EMA (200) | 32.91 | BUY |
| SMA (200) | 32.70 | BUY |
The fund seeks investments whose prices will increase over time. It normally invests at least 80% of its investable assets in equity and equity-related securities of companies within the health sciences sector, such as pharmaceutical companies, biotechnology companies, medical device manufacturers, healthcare service providers and health maintenance organizations (HMOs) and other companies that derive at least 50% of their assets, revenues or profits from operations in the healthcare sector.
Background via Yahoo Finance — informational, not part of the verdict.
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
The questions worth asking about any verdict on this page, answered plainly.
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
NO DATA 0 buys · 0 sells
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-09-08 · Asset managers net 912361 (-21819)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.